BioNexus Gene Lab Stock

BioNexus Gene Lab Net Margin

The Net Profit Margin of BioNexus Gene Lab (BGLC) as of Aug 1, 2026 is -16.81 %. In the previous year, Net Profit Margin was -26.91 % — a change of -37.54% (higher).

Net Margin

-16.81 %

YoY

-37.54%

Last updated:

Net Profit Margin of BioNexus Gene Lab is 2026 -16.81 % . Net Profit Margin of BioNexus Gene Lab was 2025 -26.91 % . It decreases by -37.54% higher compared to the previous year.

BioNexus Gene Lab's net margin stands at -16.8%, down from 9.6% several years earlier.

Access this data via the Eulerpool API

BioNexus Gene Lab Stock analysis

What does BioNexus Gene Lab do? BioNexus Gene Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNexus Gene Lab stock

Net Profit Margin of BioNexus Gene Lab is -16.81 % in 2026.

Access this data via the Eulerpool API

Margins — BioNexus Gene Lab

All Key Metrics — BioNexus Gene Lab